µTASWako™ DCP Test
Product information
µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).
DCP (des-gamma-carboxy prothrombin) is an immature form of the coagulation protein, prothrombin. In the normal metabolism the prothrombin precursor undergoes a vitamin K dependent of carboxylation of 10 glutamicacid residues at the N-terminus to yield the native prothrombin. In the case of HCC, this transformation is impaired, which results in an accumulation of DCP. DCP is also known as protein induced by vitamin K absence or antagonist II (PIVKA-II).
µTASWako™ DCP Test allows an early diagnosis of HCC and is run on the µTASWako™ i30 device.
All test components are CE-certified according to Directive 98/79/EC on in vitro diagnostic medical devices.
Click here for more information for Health Care Providers.
Safety Information
Downloads / Technical information
Flyer & brochures
Package insert
Label symbols
- Product Label Symbols_BG
- Product Label Symbols_CZ
- Product Label Symbols_DE
- Product Label Symbols_DK
- Product Label Symbols_EL
- Product Label Symbols_EN
- Product Label Symbols_ES
- Product Label Symbols_FR
- Product Label Symbols_HU
- Product Label Symbols_IT
- Product Label Symbols_LT
- Product Label Symbols_LV
- Product Label Symbols_NL
- Product Label Symbols_NR
- Product Label Symbols_PL
- Product Label Symbols_PT
- Product Label Symbols_RO
- Product Label Symbols_RU
- Product Label Symbols_SK
- Product Label Symbols_TR